-

Ivermectin Plus Mebendazole: Mechanisms, Observational Outcomes, and the Case for Randomized Trials
By Peter A. McCullough, MD, MPH If you or a loved one…
-

Fall Campus Mises Book Clubs
This fall, students from across the US are participating in Mises Book…
-

VIDEO: A Message to Radicals and Moderates
Prof. Dr. Karl-Friedrich Israel delivers the Laudatio in honor of Dr. Ron…
Editor’s Choice
About the Journal
This initiative exists to help insure that policies in public health practice and law are founded on a full consideration of available knowledge derived by robust science. From Dr Lyons-Weiler: “While IPAK will continue to conduct basic, clinical and translational biomedical research in a completely unbiased manner, and will pubish results regardless of the outcome, it will also be increasingly centered on questions of policy and law that impact public health, laws that impact public health, and cases and rulings that impact the citizen’s expression of self-governance through law. We’re putting the Public back into Public Health.”
















